HUT50150A - Process for production of six-cyclical compounds containing oxygen and medical compositions containing them as active substance
- Google Patents
Process for production of six-cyclical compounds containing oxygen and medical compositions containing them as active substance
Info
Publication number
HUT50150A
HUT50150AHU883233AHU323388AHUT50150AHU T50150 AHUT50150 AHU T50150AHU 883233 AHU883233 AHU 883233AHU 323388 AHU323388 AHU 323388AHU T50150 AHUT50150 AHU T50150A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP88109527Aexternal-prioritypatent/EP0346511A1/en
Application filed by Fujisawa Pharmaceutical CofiledCriticalFujisawa Pharmaceutical Co
Priority to HU883233ApriorityCriticalpatent/HU205100B/en
Publication of HUT50150ApublicationCriticalpatent/HUT50150A/en
Publication of HU205100BpublicationCriticalpatent/HU205100B/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Tetralydropyran and 1,3-dioxane cpd. of formula (I) and pharmaceutically acceptable salts are new, where R1 = H or lower alkyl; R2 = opt. protected carboxy-lower alkyl; R3 = -CH2-NH-R4, -CH=N-R4 or -CH2-R5; R4 = acyl, acylamino, heterocyclic amino, heterocyclic-lower alkyl or aryl-lower alkoxy; R5 = acyloxy or heterocyclic-lower alkoxy; and X = -O- or -CH2-. - Specifically claimed are (2R,4R,5S)-5-((Z)-6-carboxy -2-hexenyl)-2-methyl-4-(4 -phenylsemicarbazonomethyl -1,3-dioxane and (2R,4R,5S)-5-((Z)-6-carboxy -2-hexenyl)-2-methyl-4 -(4-(phenyl thiosemi carbazonomethyl)-1,3-dioxane.
HU883233A1988-06-151988-06-27Process for producing oxygen-cotaining six-member-hetrocyclic compounds and pharmaceutical compositions comprising same as active ingredient
HU205100B
(en)
Process for production of derivatives of sulphonanilid with effect decreasing of blood-pressure and medical compositions containing them as active substance
Process for producing ether derivatives and thioether derivatives, as well as pharmaceutical compositions comprising these compounds as active ingredient
Legal Events
Date
Code
Title
Description
HMM4
Cancellation of final prot. due to non-payment of fee